NCT02672436View on ClinicalTrials.gov

ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

October 3, 2019

Study Completion Date

December 26, 2019

Conditions
Diabetic FootFoot UlcerDiabetes MellitusWounds
Interventions
DRUG

ENERGI-F703

Standard of care and ENERGI-F703 are applied for treatment of diabetic foot ulcers.

DRUG

ENERGI-F703 matched vehicle

Standard of care and ENERGI-F703 matched vehicle are applied for treatment of diabetic foot ulcers.

Trial Locations (1)

Unknown

Tri-Service General Hospital, Taipei

Sponsors
All Listed Sponsors
collaborator

A2 Healthcare Taiwan Corporation

INDUSTRY

lead

Energenesis Biomedical Co., Ltd.

INDUSTRY